Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study June 2025 Congress News Read more
2021 November Science High hyperdiploid risk profile for childhood acute lymphoblastic leukaemia Read more
2021 November Clinical trials Omiducibel improves platelet recovery in umbilical cord blood transplantation Read more
2021 November Clinical trials BTK inhibitor plus CXCR-4 antagonist for CXCR4 mutated Waldenström macroglobulinemia Read more
2021 November Clinical trials New combination therapy for resistant or relapsed immune thrombocytopenia (ITP) patients Read more
2021 November Science Loss of PD-1 is associated with poor outcome in Cutaneous T-cell Lymphoma Read more
Top
